FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Raymond James Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Strong Buy
Tweet Send to a Friend
(Updated - October 12, 2026 5:06 AM EDT)
Raymond James analyst Chris Raymond upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Chris Raymond upgraded BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
